Diabetes to Arthritis: California Awards $33 Million for Clinical Stage Stem Cell Work
The California stem cell agency today approved nearly $33 million for clinical stage research projects testing treatments for type 1 diabetes, arthritis of the knee, ALS and an immunodeficiency affliction.
The awards were quickly approved with little discussion during a meeting at the Oakland headquarters of the California Institute for Regenerative Medi…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.